Bacteria and sputum inflammatory cell counts; a COPD cohort analysis

  • PDF / 1,914,632 Bytes
  • 13 Pages / 595.276 x 790.866 pts Page_size
  • 13 Downloads / 147 Views

DOWNLOAD

REPORT


Open Access

RESEARCH

Bacteria and sputum inflammatory cell counts; a COPD cohort analysis Augusta S. Beech1,2*  , Simon Lea1, Umme Kolsum1, Zhang Wang3, Bruce E. Miller4, Gavin C. Donaldson5, Jadwiga A. Wedzicha5, Christopher E. Brightling6 and Dave Singh1,2

Abstract  Background:  There is evidence that bacterial colonisation in chronic obstructive pulmonary disease (COPD) is associated with increased neutrophilic airway inflammation. This study tested the hypothesis that different bacterial phyla and species cause different inflammatory profiles in COPD patients. Methods:  Sputum was analysed by quantitative polymerase chain reaction (qPCR) to quantify bacterial load and 16S rRNA gene sequencing to identify taxonomic composition. Sputum differential cell counts (DCC) and blood DCC were obtained at baseline and 6 months. Patients were categorised into five groups based on bacterial load defined by genome copies/ml of ≥ 1 × 104, no colonisation and colonisation by Haemophilus influenzae (H. influenzae), Moraxella catarrhalis (M. catarrhalis), Streptococcus pneumoniae (S. pneumoniae), or > 1 potentially pathogenic microorganism (PPM). Results:  We observed an increase in sputum neutrophil (%), blood neutrophil (%) and neutrophil–lymphocyte ratio (NLR) in patients colonised with H. influenzae (82.6, 67.1, and 3.29 respectively) compared to those without PPM colonisation at baseline (69.5, 63.51 and 2.56 respectively) (p  1PPM group consisted of patients with colonisation of two or three PPMs; 92% were colonised with H. influenzae, with 58% colonised with H. influenzae + S. pneumoniae, while 42% showed evidence of M. catarrhalis colonisation and 8.3% were colonised with all three bacterial species (for details see Additional file 1, Table S1). The total number of patients in the entire cohort with M. catarrhalis colonisation was 19 (8.1%). There was no difference in bacterial colonisation in frequent exacerbators (≥ 2 exacerbations in the previous year) compared to non-frequent exacerbators (Additional file  1, Table  S2), or in patients using ICS compared to those not using ICS (data not shown). Sputum cell counts

145 patients with qPCR data had sputum DCCs available; induced samples were more cellular based on total cell count (× 106/g), with total neutrophil and macrophage counts (× 106/g) also higher in induced samples in the subset with this information available (n = 112). However, in the total sample (n = 143) with available DCCs, the sputum cell percentages between induced

Page 3 of 13

Table  1 Baseline demographics of  patients enrolled onto this study Characteristic

n = 236

Gender (% male)

74

Age

69.5 (8.3)

Smoking status (current %)

34

Pack years

47.5 [10–220]

BMI (kg/m2)

26.3 [17.3–47.0]

Exacerbations (1 year period)

1 [0–15]

Post ­FEV1 (L)

1.5 (0.6)

Post ­FEV1 (%)

57.4 (18.5)

CAT​

18 (7.5)

SGRQ-C (total)

47.0 (18.2)

GOLD

2 [1–4]

 1 (%)

12.0

 2 (%)

52.1

 3 (%)

29.1

 4 (%)

6.8

LABA only (%)

2.5

LAMA only (%)

5.5

ICS only (%)

1.7

ICS + LABA (%)

13.1

ICS + LAMA (%)